** Shares of the medical equipment service provider AGTI.N
rise 1.36% to $14.93 in premarket trade, after multiple
brokerages initiate coverage on the stock
** At least three brokerages, including Jefferies and
Goldman Sachs, assume coverage with a "buy" rating, while
Raymond James and BMO initiate with "outperform"
** Raymond James says co has a competitive advantage as it
has a broad service offering, and has a national reach that is
able to service a wide variety of customers and is unparalleled
relative to its competitors
** Citi Research says co has only 13% shares of the current
market and suggests that M&A presents opportunity to further
augment growth
** Adds that COVID-19 could set up a difficult near-term
comp, but believes that the pandemic enforced its position and
relationship with customers
** Up to Monday's close, stock had risen ~5% from its IPO
prices of $14 per share on April 22
(Reporting by Amal S in Bengaluru)
((Amal.S@thomsonreuters.com; within U.S.+1 646 223 8780;
outside U.S. +91 80 6749 3677;))